STALEY CAPITAL ADVISERS’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-40,000
Closed -$558K 174
2018
Q2
$558K Hold
40,000
0.04% 102
2018
Q1
$613K Buy
+40,000
New +$572K 0.05% 94
2015
Q4
Sell
-9,586
Closed -$302K 130
2015
Q3
$302K Hold
9,586
0.04% 103
2015
Q2
$464K Sell
9,586
-354
-4% -$14.9K 0.05% 86
2015
Q1
$431K Sell
9,940
-6,278
-39% -$226K 0.05% 88
2014
Q4
$427K Buy
+16,218
New +$356K 0.05% 85

Other funds holding PGEN

STALEY CAPITAL ADVISERS's PGEN Position: Q3 2018 in Review

STALEY CAPITAL ADVISERS sold out of Precigen (PGEN) in Q3 2018, closing a stake of 40,000 shares — an estimated $558K sold.

STALEY CAPITAL ADVISERS first reported a position in PGEN in Q4 2014 and held it in 6 quarters. The position peaked at $613K in Q1 2018. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2018.

  • STALEY CAPITAL ADVISERS reported no remaining Precigen position as of Q3 2018 after selling out during the quarter.
  • STALEY CAPITAL ADVISERS sold 40,000 Precigen shares in Q3 2018, an estimated $558K.
  • STALEY CAPITAL ADVISERS first reported a position in Precigen in Q4 2014 and held it in 6 quarters.
  • STALEY CAPITAL ADVISERS's Precigen position peaked at $613K in Q1 2018.
  • 170 funds tracked by Wall St. Rank held Precigen as of Q3 2018.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q3 2018, filed 9 Nov 2018.